FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893671817> ?p ?o ?g. }

• W2893671817 endingPage "35744" @default.
• W2893671817 startingPage "35734" @default.
• W2893671817 abstract "Both production of DNA damage and subsequent prevention of its repair are crucial in concluding the therapeutic outcome of radiotherapy (RT). However, nearly all current strategies for improving RT focus only on one of the two aspects and overlook the necessity of their combinations. In this work, we introduce a concept of DNA-dual-targeting nanomedicine (NM) to simultaneously enhance DNA lesion formation and prevent the succeeding repair. Briefly, the cisplatin prodrug loaded in NM can form platinated DNA in cell nuclei, making DNA more vulnerable to the ionizing radiation generated by RT. Concomitantly, the spatial-temporally codelivered vorinostat, a histone deacetylase inhibitor, prolongs the build-up of double-strand breaks and causes cell apoptosis en masse, probably due to the suppressed expression of DNA repair proteins. Furthermore, this nanoplatform is suitable for fluorescence and magnetic resonance imaging techniques, enabling accurate trafficking of the NM as well as reliable real-time imaging-guided precision RT. Finally, results from in vitro and in vivo jointly reveal that this dual-action system attains a remarkably enhanced radiotherapeutic outcome. In conclusion, our imaging-guided DNA-dual-targeting design represents a novel strategy for efficient cancer precision RT." @default.
• W2893671817 created "2018-10-05" @default.
• W2893671817 creator A5008172601 @default.
• W2893671817 creator A5009315934 @default.
• W2893671817 creator A5018755828 @default.
• W2893671817 creator A5021967675 @default.
• W2893671817 creator A5030332840 @default.
• W2893671817 creator A5036674320 @default.
• W2893671817 creator A5038008601 @default.
• W2893671817 creator A5040972296 @default.
• W2893671817 creator A5042241049 @default.
• W2893671817 creator A5043257116 @default.
• W2893671817 creator A5052139277 @default.
• W2893671817 creator A5063575243 @default.
• W2893671817 creator A5065243448 @default.
• W2893671817 date "2018-09-26" @default.
• W2893671817 modified "2023-10-14" @default.
• W2893671817 title "Cancer Chemoradiotherapy Duo: Nano-Enabled Targeting of DNA Lesion Formation and DNA Damage Response" @default.
• W2893671817 cites W1484334610 @default.
• W2893671817 cites W1855057195 @default.
• W2893671817 cites W1912124796 @default.
• W2893671817 cites W1971621147 @default.
• W2893671817 cites W1976385056 @default.
• W2893671817 cites W1981053807 @default.
• W2893671817 cites W2003601710 @default.
• W2893671817 cites W2014433188 @default.
• W2893671817 cites W2016899305 @default.
• W2893671817 cites W2029520190 @default.
• W2893671817 cites W2038636572 @default.
• W2893671817 cites W2046345187 @default.
• W2893671817 cites W2047321005 @default.
• W2893671817 cites W2051693871 @default.
• W2893671817 cites W2052073718 @default.
• W2893671817 cites W2059971436 @default.
• W2893671817 cites W2060551076 @default.
• W2893671817 cites W2065087624 @default.
• W2893671817 cites W2074730941 @default.
• W2893671817 cites W2075647502 @default.
• W2893671817 cites W2080091719 @default.
• W2893671817 cites W2094144162 @default.
• W2893671817 cites W2094665364 @default.
• W2893671817 cites W2096210342 @default.
• W2893671817 cites W2120261970 @default.
• W2893671817 cites W2146320180 @default.
• W2893671817 cites W2146399575 @default.
• W2893671817 cites W2156439911 @default.
• W2893671817 cites W2158787062 @default.
• W2893671817 cites W2165921162 @default.
• W2893671817 cites W2198709783 @default.
• W2893671817 cites W2212776653 @default.
• W2893671817 cites W2290808634 @default.
• W2893671817 cites W2297165632 @default.
• W2893671817 cites W2309569522 @default.
• W2893671817 cites W2314261970 @default.
• W2893671817 cites W2320241292 @default.
• W2893671817 cites W2342772553 @default.
• W2893671817 cites W2415000849 @default.
• W2893671817 cites W2426017016 @default.
• W2893671817 cites W2470483953 @default.
• W2893671817 cites W2526553282 @default.
• W2893671817 cites W2530048712 @default.
• W2893671817 cites W2530681900 @default.
• W2893671817 cites W2565036639 @default.
• W2893671817 cites W2566571640 @default.
• W2893671817 cites W2582585325 @default.
• W2893671817 cites W2590680367 @default.
• W2893671817 cites W2603097129 @default.
• W2893671817 cites W2608236935 @default.
• W2893671817 cites W2609892022 @default.
• W2893671817 cites W2738494405 @default.
• W2893671817 cites W2747517815 @default.
• W2893671817 cites W2751848811 @default.
• W2893671817 cites W2767074976 @default.
• W2893671817 cites W2774702937 @default.
• W2893671817 cites W2795267732 @default.
• W2893671817 cites W2807358321 @default.
• W2893671817 doi "https://doi.org/10.1021/acsami.8b10901" @default.
• W2893671817 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30255704" @default.
• W2893671817 hasPublicationYear "2018" @default.
• W2893671817 type Work @default.
• W2893671817 sameAs 2893671817 @default.
• W2893671817 citedByCount "28" @default.
• W2893671817 countsByYear W28936718172018 @default.
• W2893671817 countsByYear W28936718172019 @default.
• W2893671817 countsByYear W28936718172020 @default.
• W2893671817 countsByYear W28936718172021 @default.
• W2893671817 countsByYear W28936718172022 @default.
• W2893671817 countsByYear W28936718172023 @default.
• W2893671817 crossrefType "journal-article" @default.
• W2893671817 hasAuthorship W2893671817A5008172601 @default.
• W2893671817 hasAuthorship W2893671817A5009315934 @default.
• W2893671817 hasAuthorship W2893671817A5018755828 @default.
• W2893671817 hasAuthorship W2893671817A5021967675 @default.
• W2893671817 hasAuthorship W2893671817A5030332840 @default.
• W2893671817 hasAuthorship W2893671817A5036674320 @default.
• W2893671817 hasAuthorship W2893671817A5038008601 @default.
• W2893671817 hasAuthorship W2893671817A5040972296 @default.
• W2893671817 hasAuthorship W2893671817A5042241049 @default.

• next